1993
DOI: 10.1016/0003-4975(93)90475-w
|View full text |Cite
|
Sign up to set email alerts
|

Improved multiorgan function after prolonged univentricular support

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

1995
1995
2018
2018

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 47 publications
(13 citation statements)
references
References 15 publications
0
13
0
Order By: Relevance
“…In most of these studies, improvement in renal function to "normal" values (serum creatinine 1.0-1.3 mg/dl) was demonstrated in patients when pre-existing RD was mild to moderate (serum creatinine 1.4-1.9 mg/dl), regardless of whether a pulsatile or continuousflow LVAD was implanted (17,27,45,46,50,60). In addition, several studies have demonstrated dramatic improvements in renal function after LVAD implantation in patients with baseline creatinine values of 3.1-4.1 mg/dl and even in those dependent on CRRT before LVAD implantation (23,27,47,58,(61)(62)(63)(64).…”
Section: Improvement Of Rd After Lvad Placementmentioning
confidence: 99%
“…In most of these studies, improvement in renal function to "normal" values (serum creatinine 1.0-1.3 mg/dl) was demonstrated in patients when pre-existing RD was mild to moderate (serum creatinine 1.4-1.9 mg/dl), regardless of whether a pulsatile or continuousflow LVAD was implanted (17,27,45,46,50,60). In addition, several studies have demonstrated dramatic improvements in renal function after LVAD implantation in patients with baseline creatinine values of 3.1-4.1 mg/dl and even in those dependent on CRRT before LVAD implantation (23,27,47,58,(61)(62)(63)(64).…”
Section: Improvement Of Rd After Lvad Placementmentioning
confidence: 99%
“…End-organ function may be preserved, or perturbations in function may reverse with improved perfusion, thus improving transplant suitability and outcome. 153 Therapeutic Recommendations. Recommendation 37: Institution of mechanical cardiac support should be considered in patients without structural congenital heart disease, who manifest acute low cardiac output or who have intractable arrhythmias during a presumably temporary condition that is refractory to medical therapy (HF Stage D) such as myocarditis, septic shock, or acute rejection following cardiac transplantation.…”
Section: Risks and Benefitsmentioning
confidence: 99%
“…Once supported, patients have resolution of their heart failure state, improved survival to transplantation, and enhanced quality of life and functional status [13,1218]. Continued developments in VAD technology and increasing clinical experience with VADs have resulted in improved patient outcomes over time [11,1923].…”
Section: Introductionmentioning
confidence: 99%